high discontinuation rates (e.g., 5067 %% at one year and 85 % at two years [[5], [6], [7], [8]]) that may relate to side effects, costs, variable individual efficacy, or patient preferences [5,9]
Current scientific evidence does not support ideas such as losing weight automatically or melting fat without effort
Of the 39 companies we reviewed, 13% are publicly traded and 44% are venture-backed
The abdomen has slightly faster absorption in clinical data, but the difference is not clinically significant for most patients
Playbook Price increase versus pack-size reduction
employers heading into 2027, a trend driven by climbing overall costs that have persisted even as the per-unit price of individual medications has declined